Psychotic Disorder-Psychosis
Cluster Number:
Wiki Number: PW179-(This is a long and thorough article in Wikipedia. To be fair, please read the article entirely.)
Diagnosis: Psychotic Disorder-Psychosis
US Patients: 15% have auditory hallucinations; visual 55% of those with psychosis;
World Patients:
Sex Ratio:
Age Onset:
Brain Area: Dopamine matters.//Catatonia-physically agitated state; gray matter (interpreting life) is less; affects most brain areas.
Symptoms: Contrasting real and not real with hallucinations, delusions, incoherent speech, inappropriate behaviors & thought disorganization
Progression; auditory hallucinations now more common than visual ones; persecutory and grandure are the most common among delusions
Causes: schizophrenia, bipolar, sleep deprivation, drugs, alcohol and pot, substance abuse, childhood trauma,
Medications: antipsychotics
Therapies: social support
Youtube Video:
Psychotic Disorders: Current Concepts and Therapeutics
Amazon or Library Book: Understanding Psychosis and Schizophrenia
Click the book to link or order from Amazon.
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.03.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Detecting schizophrenia, bipolar disorder, psychosis vulnerability and major depressive disorder from 5 minutes of online-collected speechby Julianna Olah on September 16, 2024
CONCLUSION: Our ML pipeline demonstrated disorder-specific learning, achieving excellent or good accuracy across several classification tasks. We demonstrated that the screening of mental disorders is possible via a fully automated, remote speech assessment pipeline. We tested our model on relatively high number conditions (5 classes) in the literature and in a stratified sample of psychosis spectrum, including HC, SPE, SSD and BD (4 classes). We tested our model on a large sample (N = 1150) and...
- Psychometric Evaluation of Screens for Common Mental Disorders, Severe Mental Disorders, Substance Use Disorders, and Suicide Risk in Mozambican Healthcareby Kathryn L Lovero on September 13, 2024
Globally, mental and substance use disorders are a leading cause of disease burden. In low- and middle-income countries, where there is an extreme shortage of trained mental health specialists, validated, brief screening tools for mental and substance use disorders are required for non-specialists to efficiently identify patients in need of mental health care. Mozambique, one of the poorest countries in the world, has fewer than two mental health specialists for every 100,000 people. In the...
- Prior psychiatric morbidity and differential psychopharmacological treatment patterns: Exploring the heterogeneity of bipolar disorder in a nationwide study of 9594 patientsby Aswin Ratheesh on April 22, 2024
CONCLUSION: The pharmacological treatment of BD is linked to psychiatric morbidity preceding its diagnosis. Assuming that these associations reflect well-informed clinical decisions, this knowledge may inform future clinical trials by taking participants' prior morbidity into account in treatment allocation.
- DSM-5 conduct disorder and symptoms in youths at high risk of psychosis in Kenya with DSM-5 mental disorders and substance use: towards integrated managementby David M Ndetei on December 22, 2023
Little is known about the prevalence of Conduct Disorder (CD) and symptoms of CD in high risk psychosis persons at both clinical and community populations in LMICs and in particular Kenya. This study aimed to document (1) the prevalence of CD diagnosis and symptoms in youth who screened positive for psychosis and (2) the associated mental disorders and substance use in the same cohort in LMIC. The sample size was 536 students who had screened positive on the Washington Early Recognition Center...